Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Mar;18(3):180-3.
doi: 10.1097/IJG.0b013e31817eee0b.

Repeat selective laser trabeculoplasty

Affiliations

Repeat selective laser trabeculoplasty

Bryan Kun Hong et al. J Glaucoma. 2009 Mar.

Abstract

Purpose: To evaluate the efficacy of repeat 360-degree selective laser trabeculoplasty (SLT) in glaucoma patients with prior successful 360-degree SLT.

Design: Retrospective chart review.

Methods: Forty-four eyes of 35 patients, > or =18 years of age, with open-angle glaucoma (primary open-angle, pseudoexfoliation, or pigmentary glaucoma), uncontrolled on maximum tolerable medical therapy, underwent an initial 360-degree SLT (SLT1), which was successful for > or =6 months, but eventually lost efficacy and was followed by a repeat 360-degree SLT (SLT2). Patients with prior argon laser trabeculoplasty or other glaucoma surgery, before or during the study period, were excluded. Intraocular pressure (IOP) measurements were recorded before each procedure and 1 to 4 weeks, 1 to 3 months, and 5 to 8 months posttreatment and 15 to 21 weeks after the initial SLT.

Results: Reduction in IOP after SLT1 and SLT2 was significantly less with repeat treatment at 1 to 3 months, with average decreases of -5.0 and -2.9 mm Hg, respectively (P=0.01), but there were no statistically significant differences between treatments at the other equivalent time points. Using a definition of "success" as > or =20% peak IOP reduction, success rates for SLT1 and SLT2 were not significantly different. There was also no significant difference in eyes that received SLT2 6 to 12 months after SLT1 compared with those that received SLT2 12 months or more after SLT1.

Conclusions: Our findings suggest that repeat 360-degree SLT may be safe and effective after an initially successful 360-degree SLT has failed. These results may be achieved as early as 6 months after the first treatment.

PubMed Disclaimer

References

    1. Latina M, Park C. Selective targeting of trabecular meshwork cells: In vitro studies of pulsed and CW laser interactions. Exp Eye Res. 1995;60:359–372. - PubMed
    1. Damji KF, Shah KC, Rock WJ, Bains HS, Hodge WG. Selective laser trabeculoplasty v. argon laser trabeculoplasty: a prospective randomized clinical trial. Br J Ophthalmol. 1999;83:718–722. - PMC - PubMed
    1. Richter CU, Shingleton BJ, Bellows AR, Hutchinson BT, Jacobson LP. Retreatment with argon laser trabeculoplasty. Ophthalmology. 1987;94:1085–1089. - PubMed
    1. Weber PA, Burton GD, Epitropoulos AT. Laser trabeculoplasty retreatment. Ophthalmic Surg. 1989;20:702–706. - PubMed
    1. Starita RJ, Fellman RL, Spaeth GL, Poryzees E. The effect of repeating full-circumference argon laser trabeculoplasty. Ophthalmic Surg. 1984;15:41–43. - PubMed

Publication types